{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:13:10Z","timestamp":1790932390576,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-4","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T07:21:59Z","timestamp":1357197719000},"source":"Crossref","is-referenced-by-count":68,"title":["Human endogenous retroviruses and cancer prevention: evidence and prospects"],"prefix":"10.1186","volume":"13","author":[{"given":"Luca","family":"Cegolon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Salata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vineis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"issue":"Suppl","key":"3622_CR1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.ypmed.2011.11.012","volume":"54","author":"KH Wagner","year":"2012","unstructured":"Wagner KH, Brath H: A global view on the development of non communicable diseases. Prev Med. 2012, 54 (Suppl): S38-41.","journal-title":"Prev Med"},{"key":"3622_CR2","volume-title":"Int J Cancer","author":"F Bray","year":"2012","unstructured":"Bray F, Ren JS, Masuyer E, Ferlay J: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2012, 10.1002\/ijc.27711. [Epub ahead of print]"},{"issue":"3","key":"3622_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6605148","volume":"101","author":"J Maddams","year":"2009","unstructured":"Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, M\u00f8ller H: Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer. 2009, 101 (3): 541-7. 10.1038\/sj.bjc.6605148.","journal-title":"Br J Cancer"},{"key":"3622_CR4","volume-title":"SEER Cancer Statistics Review, 1975-2005","year":"2007","unstructured":"SEER Cancer Statistics Review, 1975-2005. Edited by: Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ. 2007, Bethesda, MD: National Cancer Institute, http:\/\/seer.cancer.gov\/csr\/1975_2005 . Accessed July 2008"},{"issue":"12","key":"3622_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/jnci\/djn175","volume":"100","author":"JL Warren","year":"2008","unstructured":"Warren JL, Yabroff KR, Meekins A, et al: Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008, 100 (12): 888-897. 10.1093\/jnci\/djn175.","journal-title":"J Natl Cancer Inst"},{"key":"3622_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"AB Mariotto","year":"2011","unstructured":"Mariotto AB, Yabroff KB, Shao Y, Feuer EJ, Brown ML: Projections of the cost of cancer care in the United States: 2010\u20132020. JNCI. 2011, 103: 117-123. 10.1093\/jnci\/djq495.","journal-title":"JNCI"},{"key":"3622_CR7","volume-title":"Interim Projections Consistent With Census 2000 (released March 2004)","author":"U.S. Census Bureau, Population Division","year":"2008","unstructured":"U.S. Census Bureau, Population Division: Interim Projections Consistent With Census 2000 (released March 2004). 2008, Population Division, Washington D.C: U.S. Census Bureau, http:\/\/www.census.gov\/population\/www\/projections\/usinterimproj\/ . Accessed July 2008"},{"key":"3622_CR8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s00432-010-0949-x","volume":"136","author":"B Krone","year":"2010","unstructured":"Krone B, Grange JM: Melanoma, Darwinian medicine and the inner world. J Cancer Res Clin Oncol. 2010, 136: 1787-1794. 10.1007\/s00432-010-0949-x.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3622_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-065X.2010.00987.x","volume":"240","author":"GA Rook","year":"2011","unstructured":"Rook GA, Dalgleish A: Infection, immunoregulation, and cancer. Immunol Rev. 2011, 240: 141-159. 10.1111\/j.1600-065X.2010.00987.x.","journal-title":"Immunol Rev"},{"key":"3622_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"International Human Genome Sequencing Consortium (IHGSC)","year":"2001","unstructured":"International Human Genome Sequencing Consortium (IHGSC): Initial sequencing and analysis of the human genome. Nature. 2001, 409: 860-921. 10.1038\/35057062.","journal-title":"Nature"},{"key":"3622_CR11","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.1089670","volume":"303","author":"HH Kazazian","year":"2004","unstructured":"Kazazian HH: Mobile elements: drivers of genome evolution. Science. 2004, 303: 1626-1632. 10.1126\/science.1089670.","journal-title":"Science"},{"key":"3622_CR12","doi-asserted-by":"crossref","first-page":"1017.1","DOI":"10.1186\/gb-2001-2-6-reviews1017","volume":"2","author":"DL Griffiths","year":"2001","unstructured":"Griffiths DL: Endogenous retroviruses in the human genome sequence. Genome Biol. 2001, 2: 1017.1-1017.5.","journal-title":"Genome Biol"},{"key":"3622_CR13","first-page":"129","volume":"10","author":"A Friedlander","year":"1999","unstructured":"Friedlander A, Patarca R: Endogenous proviruses. Crit Rev Oncog. 1999, 10: 129-159.","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"3622_CR14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrmicro2783","volume":"10","author":"JP Stoye","year":"2012","unstructured":"Stoye JP: Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol. 2012, 10 (6): 395-406.","journal-title":"Nat Rev Microbiol"},{"key":"3622_CR15","doi-asserted-by":"publisher","first-page":"14572","DOI":"10.1073\/pnas.0404838101","volume":"101","author":"N Bannert","year":"2004","unstructured":"Bannert N, Kurth R: Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci USA. 2004, 101: 14572-14579. 10.1073\/pnas.0404838101.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3622_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/35057039","volume":"409","author":"WH Li","year":"2001","unstructured":"Li WH, Gu Z, Wang H, et al: Evolutionary analyses of the human genome. Nature. 2001, 409: 847-49. 10.1038\/35057039.","journal-title":"Nature"},{"key":"3622_CR17","first-page":"1109","volume-title":"RNA Tumor Viruses","author":"J Coffin","year":"1984","unstructured":"Coffin J: Endogenous viruses. RNA Tumor Viruses. Edited by: Weiss R, Teich N, Varmus H, Coffin J. 1984, Cold Spring Harbor, NY: Cold Spring Harbor Press, 1109-1203. 2","edition":"2"},{"key":"3622_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/0092-8674(80)90537-1","volume":"22","author":"RA Weinberg","year":"1980","unstructured":"Weinberg RA: Origins and roles of endogenous retroviruses. Cell. 1980, 22: 643-4. 10.1016\/0092-8674(80)90537-1.","journal-title":"Cell"},{"key":"3622_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/284601a0","volume":"284","author":"WF Dolittle","year":"1980","unstructured":"Dolittle WF, Sapienza C: Selfish genes, the phenotype paradigm and genome evolution. Nature. 1980, 284: 601-3. 10.1038\/284601a0.","journal-title":"Nature"},{"key":"3622_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/284604a0","volume":"284","author":"L Orge","year":"1980","unstructured":"Orge L, Crick FHC: Selfish DNA. the ultimate parasite. Nature. 1980, 284: 604-7. 10.1038\/284604a0.","journal-title":"Nature"},{"key":"3622_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0092-8674(85)90190-4","volume":"40","author":"D Baltimore","year":"1985","unstructured":"Baltimore D: Retroviruses and retrotransposones: the role of reverse transcription in shaping the eukaryotic genome. Cell. 1985, 40: 481-82. 10.1016\/0092-8674(85)90190-4.","journal-title":"Cell"},{"key":"3622_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-3372-6_1","volume-title":"The Retroviridae, Vol 1","author":"HM Temin","year":"1992","unstructured":"Temin HM: Origin and general nature of retroviruses. The Retroviridae, Vol 1. Edited by: New York: Levy JA. 1992, Plenum Press, 1-18."},{"key":"3622_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0169-5347(96)81058-5","volume":"11","author":"C Zeyl","year":"1996","unstructured":"Zeyl C, Beli G: Symbiotic DNA in eukaryotic genomes. Trends Ecol EvoI. 1996, 11: 10-5. 10.1016\/0169-5347(96)81058-5.","journal-title":"Trends Ecol EvoI"},{"issue":"Pt 2","key":"3622_CR24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1099\/vir.0.83534-0","volume":"89","author":"K Boller","year":"2008","unstructured":"Boller K, Sch\u00f6nfeld K, Lischer S, Fischer N, HoVmann A, Kurth R, T\u00f6njes RR: Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol. 2008, 89 (Pt 2): 567-572.","journal-title":"J Gen Virol"},{"issue":"19","key":"3622_CR25","first-page":"5510","volume":"62","author":"F Schiavetti","year":"2002","unstructured":"Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG: A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res. 2002, 62 (19): 5510-6.","journal-title":"Cancer Res"},{"key":"3622_CR26","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1128\/JVI.79.5.2941-2949.2005","volume":"79","author":"A Flockerzi","year":"2005","unstructured":"Flockerzi A, Burkhardt S, Schempp W, Meese E, Mayer J: Human endogenous retrovirus HERV-K14 family: status, variants, evolution and mobilization of other cellular sequences. J Virol. 2005, 79: 2941-2949. 10.1128\/JVI.79.5.2941-2949.2005.","journal-title":"J Virol"},{"key":"3622_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-4690-6-37","volume":"6","author":"G Laufer","year":"2009","unstructured":"Laufer G, Mayer J, Mueller BF, Mueller-Lantzsch N, Ruprecht K: Analysis of transcribed human endogenous retrovirus W env loci clariWes the origin of multiple sclerosis-associated env sequences. Retrovirology. 2009, 6: 37-53. 10.1186\/1742-4690-6-37.","journal-title":"Retrovirology"},{"key":"3622_CR28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tig.2007.05.004","volume":"2","author":"D Moyes","year":"2007","unstructured":"Moyes D, Griffithsm DJ, Venables PJ: Insertional polymorphisms. A new lease of life for endogenous retrovirus in human disease. Trends Genet. 2007, 2: 326-333.","journal-title":"Trends Genet"},{"key":"3622_CR29","volume-title":"Virolution","author":"FP Ryan","year":"2009","unstructured":"Ryan FP: Virolution. 2009, New York: Harper Collins"},{"key":"3622_CR30","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1128\/JVI.00123-09","volume":"83","author":"E Gogvadze","year":"2009","unstructured":"Gogvadze E, Stukacheva E, Buzdin A, Sverdlov E: Human specific modulation of transcriptional activity provided by endogenous retroviral insertions. J Virol. 2009, 83: 6098-6105. 10.1128\/JVI.00123-09.","journal-title":"J Virol"},{"key":"3622_CR31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnci\/50.4.1081","volume":"50","author":"SS Kalter","year":"1973","unstructured":"Kalter SS, Helmke RJ, Heberling RL, Panigel M, Fowler AK, Strickland JE, Hellman A: Brief communication: C-type particles in normal human placentas. J Natl Cancer Inst. 1973, 50: 1081-1084.","journal-title":"J Natl Cancer Inst"},{"key":"3622_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.placenta.2004.02.008","volume":"25","author":"NS Rote","year":"2004","unstructured":"Rote NS, Chakrabarti S, Stetzer BP: The role of human endogenous retroviruses in trophoblast diVerentiation and placental development. Placenta. 2004, 25: 673-683. 10.1016\/j.placenta.2004.02.008.","journal-title":"Placenta"},{"key":"3622_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1365-3083.1998.00428.x","volume":"48","author":"E Larsson","year":"1998","unstructured":"Larsson E, Andersson G: Beneficial role of human endogenous retroviruses: facts and hypotheses. Scand J Immunol. 1998, 48: 329-338. 10.1046\/j.1365-3083.1998.00428.x.","journal-title":"Scand J Immunol"},{"key":"3622_CR34","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1747.1999.00728.x","volume":"113","author":"C Hohenadl","year":"1999","unstructured":"Hohenadl C, Germaier H, Walchner M, Hagenhofer M, Herrmann M, Sturzl M, Kind P, Hehlmann R, Erfle V, Leib-Mosch C: Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol. 1999, 113: 587-594. 10.1046\/j.1523-1747.1999.00728.x.","journal-title":"J Invest Dermatol"},{"key":"3622_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-1702(01)00280-5","volume":"79","author":"AS Khan","year":"2001","unstructured":"Khan AS, Muller J, Sears JF: Early detection of endogenous retroviruses in chemically induced mouse cells. Virus Res. 2001, 79: 39-45. 10.1016\/S0168-1702(01)00280-5.","journal-title":"Virus Res"},{"key":"3622_CR36","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1128\/JVI.61.6.2059-2062.1987","volume":"6","author":"M Ono","year":"1987","unstructured":"Ono M, Kawakami M, Ushikubo H: Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J Virol. 1987, 6: 2059-2062.","journal-title":"J Virol"},{"key":"3622_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1006\/clim.1999.4762","volume":"93","author":"K Katsumata","year":"1999","unstructured":"Katsumata K, Ikeda H, Sato M, Ishizu A, Kawarada Y, Kato H, Wakisaka A, Koike T, Yoshiki T: Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol. 1999, 93: 75-80. 10.1006\/clim.1999.4762.","journal-title":"Clin Immunol"},{"issue":"1","key":"3622_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejca.2004.08.010","volume":"41","author":"B Krone","year":"2005","unstructured":"Krone B, K\u00f6lmel KF, Henz BM, Grange JM: Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and\/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. Eur J Cancer. 2005, 41 (1): 104-17. 10.1016\/j.ejca.2004.08.010.","journal-title":"Eur J Cancer"},{"key":"3622_CR39","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1093\/nar\/gkp1214","volume":"38","author":"J Gimenez","year":"2010","unstructured":"Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, Bouton O, Mallet F: Custom human endogenous retroviruses dedicated microarray identiWes self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucl Acids Res. 2010, 38: 2229-2246. 10.1093\/nar\/gkp1214.","journal-title":"Nucl Acids Res"},{"key":"3622_CR40","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/gcc.20751","volume":"49","author":"S Stengel","year":"2010","unstructured":"Stengel S, Fiebig U, Kurth R, Denner J: Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosom Cancer. 2010, 49: 401-411. 10.1002\/gcc.20751.","journal-title":"Genes Chromosom Cancer"},{"key":"3622_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13550280802448451","volume":"15","author":"A Dolei","year":"2009","unstructured":"Dolei A, Perron H: The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics and immunology in human physiology and disease. J Neurovirol. 2009, 15: 4-13. 10.1080\/13550280802448451.","journal-title":"J Neurovirol"},{"key":"3622_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1023\/A:1024455415443","volume":"26","author":"R Gifford","year":"2003","unstructured":"Gifford R, Tristem M: The evolution distribution and diversity of endogenous retroviruses. Virus Genes. 2003, 26: 291-315. 10.1023\/A:1024455415443.","journal-title":"Virus Genes"},{"key":"3622_CR43","doi-asserted-by":"publisher","first-page":"12507","DOI":"10.1128\/JVI.79.19.12507-12514.2005","volume":"79","author":"R Belshaw","year":"2005","unstructured":"Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, Tristem M: Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K (HML-2): implications for present day activity. J Virol. 2005, 79: 12507-12514. 10.1128\/JVI.79.19.12507-12514.2005.","journal-title":"J Virol"},{"key":"3622_CR44","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1128\/JVI.74.8.3715-3730.2000","volume":"74","author":"M Tristem","year":"2000","unstructured":"Tristem M: Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol. 2000, 74: 3715-30. 10.1128\/JVI.74.8.3715-3730.2000.","journal-title":"J Virol"},{"key":"3622_CR45","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.1073\/pnas.93.11.5177","volume":"93","author":"R L\u00f6wer","year":"1996","unstructured":"L\u00f6wer R, Lower J, Kurth R: The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A. 1996, 93: 5177-5184. 10.1073\/pnas.93.11.5177.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3622_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X","volume":"22","author":"ED Sverdlov","year":"2000","unstructured":"Sverdlov ED: Retroviruses and primate evolution. Bioessays. 2000, 22: 161-171. 10.1002\/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X.","journal-title":"Bioessays"},{"key":"3622_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/6766","volume":"21","author":"J Mayer","year":"1999","unstructured":"Mayer J, Sauter M, R\u00e1cz A, Scherer D, Mueller-Lantzsch N, Meese E: An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet. 1999, 21: 257-8. 10.1038\/6766.","journal-title":"Nat Genet"},{"key":"3622_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1534\/genetics.105.043976","volume":"171","author":"JF Hughes","year":"2005","unstructured":"Hughes JF, Coffin JM: Human endogenous retroviral elements as indicators of ectopic recombination events in the primate genome. Genetics. 2005, 171: 1183-1194. 10.1534\/genetics.105.043976.","journal-title":"Genetics"},{"key":"3622_CR49","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1073\/pnas.90.10.4480","volume":"90","author":"R L\u00f6wer","year":"1993","unstructured":"L\u00f6wer R, Boller K, Hasenmaier B, Korbmacher C, Muller-Lantzsch N, Lower J, Kurth R: Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A. 1993, 90: 4480-4484. 10.1073\/pnas.90.10.4480.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3622_CR50","first-page":"8735","volume":"63","author":"T Muster","year":"2003","unstructured":"Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, Fodinger D, Seppele H, Schanab O, Magin-Lachmann C, Lower R, Jansen B, Pehamberger H, Wolff K: An endogenous retrovirus derived from human melanoma cells. Cancer Res. 2003, 63: 8735-8741.","journal-title":"Cancer Res"},{"issue":"3","key":"3622_CR51","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JVI.58.3.937-944.1986","volume":"58","author":"M Ono","year":"1986","unstructured":"Ono M: Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes. J Virol. 1986, 58 (3): 937-944.","journal-title":"J Virol"},{"key":"3622_CR52","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2164-9-354","volume":"9","author":"A Flockerzi","year":"2008","unstructured":"Flockerzi A, Ruggieri A, Frank O, Sauter M, Maldener E, Kopper B, Wullich B, Seifarth W, M\u00fcller-Lantzsch N, Leib-M\u00f6sch C, Meese E, Mayer J: Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics. 2008, 9: 354-10.1186\/1471-2164-9-354.","journal-title":"BMC Genomics"},{"issue":"2","key":"3622_CR53","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.canlet.2010.09.011","volume":"305","author":"R Sarid","year":"2011","unstructured":"Sarid R, Gao SJ: Viruses and human cancer: from detection to causality. Cancer Lett. 2011, 305 (2): 218-27. 10.1016\/j.canlet.2010.09.011.","journal-title":"Cancer Lett"},{"key":"3622_CR54","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1128\/JVI.72.10.8384-8391.1998","volume":"72","author":"W Seifarth","year":"1998","unstructured":"Seifarth W, Baust C, Murr A, Skladny H, Krieg-Schneider F, Blusch J, Werner T, Hehlmann R, Leib-Mosch C: Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. J Virol. 1998, 72: 8384-8391.","journal-title":"J Virol"},{"key":"3622_CR55","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-04-2983","volume":"65","author":"K B\u00fcscher","year":"2005","unstructured":"B\u00fcscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J: Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 2005, 65: 4172-4180. 10.1158\/0008-5472.CAN-04-2983.","journal-title":"Cancer Res"},{"key":"3622_CR56","doi-asserted-by":"publisher","first-page":"9329","DOI":"10.1128\/JVI.00646-08","volume":"82","author":"R Contreras-Galindo","year":"2008","unstructured":"Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM: Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 2008, 82: 9329-36. 10.1128\/JVI.00646-08.","journal-title":"J Virol"},{"issue":"3","key":"3622_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jnci\/djr540","volume":"104","author":"F Wang-Johanning","year":"2012","unstructured":"Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GL: Immunotherapeutic potential of anti-human endogenous retrovirus-k envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst. 2012, 104 (3): 189-210. 10.1093\/jnci\/djr540.","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"3622_CR58","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-07-6838","volume":"68","author":"F Wang-Johanning","year":"2008","unstructured":"Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Jagannadha Sastry K, Piyathilake C, Hunt KK, Johanning GL: Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients. Cancer Res. 2008, 68 (14): 5869-77. 10.1158\/0008-5472.CAN-07-6838.","journal-title":"Cancer Res"},{"key":"3622_CR59","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/sj.onc.1206241","volume":"22","author":"F Wang-Johanning","year":"2003","unstructured":"Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL: Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene. 2003, 22: 1528-1535. 10.1038\/sj.onc.1206241.","journal-title":"Oncogene"},{"issue":"6","key":"3622_CR60","first-page":"1553","volume":"7","author":"F Wang-Johanning","year":"2001","unstructured":"Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV: Expression of human endogenous retrovirus k envelope transcripts in human breast cancer. Clin Cancer Res. 2001, 7 (6): 1553-60.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3622_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.22256","volume":"120","author":"F Wang-Johanning","year":"2007","unstructured":"Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW, Johanning GL: Expression of multiple human endogenous retrovirus surface envelope proteins on ovarian cancer. Int J Cancer. 2007, 120 (1): 81-90. 10.1002\/ijc.22256.","journal-title":"Int J Cancer"},{"key":"3622_CR62","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.yexcr.2008.12.023","volume":"315","author":"A Serafino","year":"2009","unstructured":"Serafino A, Balestrierib E, Pierimarchia P, Matteucci C, Moroni G, Oricchio E, Rasia G, Mastino A, Spadafora C, Garaci E, Sinibaldi Vallebona P: The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res. 2009, 315: 849-862. 10.1016\/j.yexcr.2008.12.023.","journal-title":"Exp Cell Res"},{"issue":"6","key":"3622_CR63","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1365-2133.2009.09415.x","volume":"161","author":"S Singh","year":"2009","unstructured":"Singh S, Kaye S, Gore ME, McClure MO, Bunker CB: The role of human endogenous retroviruses in melanoma. Br J Dermatol. 2009, 161 (6): 1225-31. 10.1111\/j.1365-2133.2009.09415.x. Epub 2009 Jul","journal-title":"Br J Dermatol"},{"key":"3622_CR64","first-page":"1727","volume":"149","author":"H Herbst","year":"1996","unstructured":"Herbst H, Sauter M, Mueller-Lantzsch N: Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol. 1996, 149: 1727-1735.","journal-title":"Am J Pathol"},{"key":"3622_CR65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/sj.leu.2402355","volume":"16","author":"S Depil","year":"2002","unstructured":"Depil S, Roche C, Dussart P, Prin L: Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukaemia patients. Leukemia. 2002, 16: 254-259. 10.1038\/sj.leu.2402355.","journal-title":"Leukemia"},{"key":"3622_CR66","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood.V90.10.4022","volume":"90","author":"MT Boyd","year":"1990","unstructured":"Boyd MT, Foley B, Brodsky I: Evidence for copurification of HERV-K-related transcripts and a reverse transcriptase activity in human platelets from patients with essential thrombocythemia. Blood. 1990, 90: 4022-4030.","journal-title":"Blood"},{"key":"3622_CR67","first-page":"15","volume":"8","author":"T Ishida","year":"2008","unstructured":"Ishida T, Obata Y, Ohara N, et al: Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun. 2008, 8: 15-","journal-title":"Cancer Immun"},{"issue":"2","key":"3622_CR68","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10059-009-0107-y","volume":"28","author":"K Ahn","year":"2009","unstructured":"Ahn K, Kim HS: Structural and quantitative expression analyses of HERV gene family in human tissues. Mol Cells. 2009, 28 (2): 99-103. 10.1007\/s10059-009-0107-y.","journal-title":"Mol Cells"},{"issue":"4","key":"3622_CR69","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/j.1755-148X.2011.00860.x","volume":"24","author":"O Schanab","year":"2011","unstructured":"Schanab O, Humer J, Gleiss A, et al: Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma. Pigment Cell Melanoma Res. 2011, 24 (4): 656-65. 10.1111\/j.1755-148X.2011.00860.x.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"3622_CR70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/CMR.0b013e32833c1b5d","volume":"20","author":"J Reiche","year":"2010","unstructured":"Reiche J, Pauli G, Ellerbrok H: Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 2010, 20 (5): 435-40.","journal-title":"Melanoma Res"},{"issue":"8","key":"3622_CR71","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/aid.2010.0014","volume":"26","author":"U Gabriel","year":"2010","unstructured":"Gabriel U, Steidler A, Trojan L, et al: Smoking increases transcription of human endogenous retroviruses in a newly established in vitro cell model and in normal urothelium. AIDS Res Hum Retroviruses. 2010, 26 (8): 883-8. 10.1089\/aid.2010.0014.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"3622_CR72","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1089\/aid.2006.0117","volume":"23","author":"R Contreras-Galindo","year":"2007","unstructured":"Contreras-Galindo R, L\u00f3pez P, V\u00e9lez R, Yamamura Y: HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. 2007, 23 (1): 116-22. 10.1089\/aid.2006.0117.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3622_CR73","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1083\/jcb.200111073","volume":"156","author":"V Horsley","year":"2002","unstructured":"Horsley V, Pavlath GK: NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol. 2002, 156: 771-774. 10.1083\/jcb.200111073.","journal-title":"J Cell Biol"},{"issue":"21","key":"3622_CR74","first-page":"7920","volume":"61","author":"MH Kershaw","year":"2001","unstructured":"Kershaw MH, Hsu C, Mondesire W, et al: Immunizatiom against endogenous retroviral tumour-associated antigens. Cancer Res. 2001, 61 (21): 7920-4.","journal-title":"Cancer Res"},{"key":"3622_CR75","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1038\/sj.onc.1208562","volume":"24","author":"I Sciamanna","year":"2005","unstructured":"Sciamanna I, Landriscina M, Pittoggi C, Quirino M, Mearelli C, Beraldi R, Mattei E, Serafino A, Cassano A, Sinibaldi-Vallebona P, Garaci E, Barone C, Spadafora C, et al: Inhibition of endogenous reverse transcriptase antagonizes human tumor growth. Oncogene. 2005, 24: 3923-31. 10.1038\/sj.onc.1208562.","journal-title":"Oncogene"},{"key":"3622_CR76","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1158\/0008-5472.CAN-04-4231","volume":"65","author":"M Mangeney","year":"2005","unstructured":"Mangeney M, Pothlichet J, Renard M, et al: Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res. 2005, 65: 2588-91. 10.1158\/0008-5472.CAN-04-4231.","journal-title":"Cancer Res"},{"key":"3622_CR77","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1038\/sj.onc.1210214","volume":"26","author":"E Oricchio","year":"2007","unstructured":"Oricchio E, Sciamanna I, Beraldi R, et al: Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 2007, 26: 4226-33. 10.1038\/sj.onc.1210214.","journal-title":"Oncogene"},{"key":"3622_CR78","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1158\/0008-5472.CAN-05-2452","volume":"66","author":"J Humer","year":"2006","unstructured":"Humer J, Waltenberger A, Grassauer A, et al: Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses. Cancer Res. 2006, 66: 1658-63. 10.1158\/0008-5472.CAN-05-2452.","journal-title":"Cancer Res"},{"key":"3622_CR79","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1089\/aid.2007.0286","volume":"24","author":"S Hahn","year":"2008","unstructured":"Hahn S, Ugurel S, Hanschmann KM, et al: Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses. 2008, 24: 717-23. 10.1089\/aid.2007.0286.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"3622_CR80","first-page":"478","volume":"191","author":"JM Grange","year":"2009","unstructured":"Grange JM, Krone B, K\u00f6lmel KF, Mastrangelo G: Can prior vaccinations against certain infections confer protection against developing melanoma?. MJA. 2009, 191 (9): 478-479.","journal-title":"MJA"},{"key":"3622_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00008390-199209000-00009","volume":"2","author":"KF Koelmel","year":"1992","unstructured":"Koelmel KF, Gefeller O, Haferkamp B: Febrile infections and malignant melanoma: results of a case-control study. Melanoma Res. 1992, 2: 207-211. 10.1097\/00008390-199209000-00009.","journal-title":"Melanoma Res"},{"issue":"16","key":"3622_CR82","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0959-8049(03)00625-7","volume":"39","author":"B Krone","year":"2003","unstructured":"Krone B, K\u00f6lmel KF, Grange JM, Mastrangelo G, Henz BM, Botev IN, Niin M, Seebacher C, Lambert D, Shafir R, Kokoschka EM, Kleeberg UR, Gefeller O, Pfahlberg A: Impact of vaccinations and infectious diseases on the risk of melanoma\u2013evaluation of an EORTC case-control study. Eur J Cancer. 2003, 39 (16): 2372-8. 10.1016\/S0959-8049(03)00625-7.","journal-title":"Eur J Cancer"},{"issue":"4","key":"3622_CR83","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.vaccine.2008.10.076","volume":"27","author":"G Mastrangelo","year":"2009","unstructured":"Mastrangelo G, Krone B, Fadda E, Buja A, Grange JM, Rausa G, de Vries E, Koelmel KF: Does yellow fever 17D vaccine protect against melanoma?. Vaccine. 2009, 27 (4): 588-91. 10.1016\/j.vaccine.2008.10.076.","journal-title":"Vaccine"},{"key":"3622_CR84","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1016\/j.vaccine.2012.04.074","volume":"30","author":"M Hodges-Vazquez","year":"2012","unstructured":"Hodges-Vazquez M, Wilson JP, Hughes H, Garman P: The yellow fever 17D vaccine and risk of malignant melanoma in the United States military. Vaccine. 2012, 30: 4476-9. 10.1016\/j.vaccine.2012.04.074.","journal-title":"Vaccine"},{"issue":"1","key":"3622_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM: Causal diagrams for epidemiologic research. Epidemiology. 1999, 10 (1): 37-48. 10.1097\/00001648-199901000-00008.","journal-title":"Epidemiology"},{"issue":"Part 4","key":"3622_CR86","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1099\/0022-1317-80-4-841","volume":"80","author":"N De Parseval","year":"1999","unstructured":"De Parseval N, Alkabbani H, Heidmann T: The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol. 1999, 80 (Part 4): 841-5.","journal-title":"J Gen Virol"},{"key":"3622_CR87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1016-8478(23)13710-1","volume":"15","author":"WJ Lee","year":"2003","unstructured":"Lee WJ, Kwun HJ, Kim HS, Jang KL: Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells. 2003, 15: 75-80.","journal-title":"Mol Cells"},{"key":"3622_CR88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/JVI.70.1.188-198.1996","volume":"70","author":"E Sjottem","year":"1996","unstructured":"Sjottem E, Anderssen S, Johansen T: The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC\/GT box located immediately 30 to the TATA box. J Virol. 1996, 70: 188-98.","journal-title":"J Virol"},{"key":"3622_CR89","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1476-4598-3-12","volume":"3","author":"L Menendez","year":"2004","unstructured":"Menendez L, Benigno BB, McDonald JF: L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer. 2004, 3: 12-10.1186\/1476-4598-3-12.","journal-title":"Mol Cancer"},{"key":"3622_CR90","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/sj.bjc.6690524","volume":"80","author":"AR Florl","year":"1999","unstructured":"Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA: DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer. 1999, 80: 1312-21. 10.1038\/sj.bjc.6690524.","journal-title":"Br J Cancer"},{"key":"3622_CR91","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1128\/JVI.79.2.876-883.2005","volume":"79","author":"L Lavie","year":"2005","unstructured":"Lavie L, Kitova M, Maldener E, Meese E, Mayer J: CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol. 2005, 79: 876-83. 10.1128\/JVI.79.2.876-883.2005.","journal-title":"J Virol"},{"key":"3622_CR92","volume-title":"Globocan","author":"International Agency for Research on Cancer (IARC)","year":"2008","unstructured":"International Agency for Research on Cancer (IARC): Globocan. 2008, Available at: http:\/\/globocan.iarc.fr . Accessed in November 2012"},{"key":"3622_CR93","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.321.7261.624","volume":"321","author":"K McPherson","year":"2000","unstructured":"McPherson K, Steel CM, Dixon JM: ABC of breast diseases. Breast cancer epidemiology, risk factors and genetics. BMJ. 2000, 321: 624-628. 10.1136\/bmj.321.7261.624.","journal-title":"BMJ"},{"key":"3622_CR94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.pu.17.050196.000403","volume":"17","author":"JL Kelsey","year":"1996","unstructured":"Kelsey JL, Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health. 1996, 17: 47-67. 10.1146\/annurev.pu.17.050196.000403.","journal-title":"Annu Rev Public Health"},{"key":"3622_CR95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-5122(00)00196-1","volume":"38","author":"BS Hulka","year":"2001","unstructured":"Hulka BS, Moorman PG: Breast cancer: hormones and other risk factors. Maturitas. 2001, 38: 103-113. 10.1016\/S0378-5122(00)00196-1. discussion 113\u2013106","journal-title":"Maturitas"},{"key":"3622_CR96","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/ijc.23595","volume":"123","author":"A Savu","year":"2008","unstructured":"Savu A, Potter J, Li S, Yasui Y: Breast cancer and microbial cancer incidence in female populations. Int J Cancer. 2008, 123: 1094-1099. 10.1002\/ijc.23595.","journal-title":"Int J Cancer"},{"issue":"1","key":"3622_CR97","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00705-004-0378-8","volume":"150","author":"HD Ejthadi","year":"2005","unstructured":"Ejthadi HD, Martin JH, Junying J, et al: A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch Virol. 2005, 150 (1): 177-184. 10.1007\/s00705-004-0378-8.","journal-title":"Arch Virol"},{"issue":"6","key":"3622_CR98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1593\/neo.07986","volume":"10","author":"M Golan","year":"2008","unstructured":"Golan M, Hizi A, Resau JH, et al: Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 2008, 10 (6): 521-533.","journal-title":"Neoplasia"},{"key":"3622_CR99","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB: The environment and disease: association or causation?. Proc R Med Soc. 1965, 58: 295-300.","journal-title":"Proc R Med Soc"},{"key":"3622_CR100","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1471-2407-8-271","volume":"8","author":"L Shack","year":"2008","unstructured":"Shack L, Jordan C, Thomson ST, Mak V, M\u00f8ller H: Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England. BMC Cancer. 2008, 8: 271-10.1186\/1471-2407-8-271.","journal-title":"BMC Cancer"},{"key":"3622_CR101","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0025-6196(11)61033-1","volume":"82","author":"SN Markovic","year":"2007","unstructured":"Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al: Malignant melanoma in the 21st century. Part 1. Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007, 82: 364-80.","journal-title":"Mayo Clin Proc"},{"key":"3622_CR102","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1011240019516","volume":"12","author":"K Yost","year":"2011","unstructured":"Yost K, Perkins C, Cohen R, Morris C, Wright W: Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups. Cancer Causes Control. 2011, 12: 703-711.","journal-title":"Cancer Causes Control"},{"key":"3622_CR103","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<56::AID-IJC11>3.0.CO;2-4","volume":"81","author":"E Pukkala","year":"1999","unstructured":"Pukkala E, Weiderpass E: Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971\u20131995). Int J Cancer. 1999, 81: 56-61. 10.1002\/(SICI)1097-0215(19990331)81:1<56::AID-IJC11>3.0.CO;2-4.","journal-title":"Int J Cancer"},{"key":"3622_CR104","first-page":"2571","volume":"60","author":"F G","year":"2000","unstructured":"G F, PL L, P M, Colombo MP: Immunoprevention of Cancer: Is the Time Ripe?. Cancer Res. 2000, 60: 2571-2575.","journal-title":"Cancer Res"},{"key":"3622_CR105","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1517\/14712598.8.11.1787","volume":"8","author":"AH Roukens","year":"2008","unstructured":"Roukens AH, Visser LG: Yellow fever vaccine: past, present and future. Expert Opin Biol Ther. 2008, 8: 1787-95. 10.1517\/14712598.8.11.1787.","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"3622_CR106","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","volume":"9","author":"B Pulendran","year":"2009","unstructured":"Pulendran B: Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol. 2009, 9 (10): 741-7.","journal-title":"Nat Rev Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T06:39:34Z","timestamp":1714804774000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3622"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]},"article-number":"4"}}